About the course
The aim of the course if to provide doctors with regional HIV treatment knowledge and expertise, by developing clinicians' abilities to effectively manage HIV complications and provide leadership in HIV prevention, treatment and care.
The 10 day programme is a busy one, faciliated by technical experts from WITS RHI, colleagues from the University of the Witwatersrand Medical School, key opinion leaders from the Society and experts from the private sector.
Required minimum criteria for applicants:
The Southern African HIV Clinicians Society is thrilled to announce that they are entering into a training partnership with WITS RHI. This partnership will see WITS RHI’s highly-regarded Clinical HIV Management Course being handed over to the Society to adapt, modernise and implement.
The aim of this course is to provide doctors with regional HIV treatment knowledge and expertise, by developing clinicians’ abilities to effectively manage HIV complications and provide leadership in HIV prevention, treatment and care.
Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners
The prevalence of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis are higher in prisons than in the general population in most countries worldwide. Prisons have emerged as a risk environment for these infections to be further concentrated, amplified, and then transmitted to the community after prisoners are released. In the absence of alternatives to incarceration, prisons and detention facilities could be leveraged to promote primary and secondary prevention strategies for these infections to improve prisoners health and reduce risk throughout incarceration and on release.
The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections.